TrialA Study for Evaluation of BIV201 to Reduce Ascites and Complications in Patients With Cirrhosis and Refractory Ascites
Trial details
- Registry ID
- NCT04112199
- Phase
- Phase 2
BIVI
BioVie Inc.
Company identity checked against sources
Browse linked trials and recorded changes, or follow this company for updates.
4Trials in this database
18Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far
Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.
Completion dates · Pro
Which trial dates moved later?
Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features
Included trials
Check company identity source| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study for Evaluation of BIV201 to Reduce Ascites and Complications in Patients With Cirrhosis and Refractory AscitesNCT04112199 | BIVI | Phase 2 | Terminated | 2023-05-08Actual |
| A Phase 3 Study of NE3107 in Probable Alzheimer's DiseaseNCT04669028 | BIVI | Phase 3 | Completed | 2023-09-30Actual |
| A Study of NE3107 in Early Parkinson'sNCT06757010 | BIVI | Phase 2 | Completed | 2026-05-01Actual |
| NE3107 in Adults With Neurological Symptoms of Long COVIDNCT06847191 | BIVI | Phase 2 | Completed | 2026-08-06Actual |
A Phase 3 Study of NE3107 in Probable Alzheimer's Disease
Trial details
- Registry ID
- NCT04669028
- Phase
- Phase 3
A Study of NE3107 in Early Parkinson's
Trial details
- Registry ID
- NCT06757010
- Phase
- Phase 2
NE3107 in Adults With Neurological Symptoms of Long COVID
Trial details
- Registry ID
- NCT06847191
- Phase
- Phase 2
Latest recorded trial changes
NE3107 in Adults With Neurological Symptoms of Long COVID
NCT06847191 · BioVie Inc.
Recruitment status changed
− Before
Active not recruiting
+ After
Completed
NE3107 in Adults With Neurological Symptoms of Long COVID
NCT06847191 · BioVie Inc.
Main study measure wording changed
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Compare wording
− Before
Measure: Change from Baseline in performance on the Cogstate Cognition battery*
+ After
Measure: Change from Baseline in performance on the Cogstate Cognition battery* Measure: Change from Baseline in PROMIS Cognitive Function Short Form 8a (SF-8a) Measure: Change from Baseline in PROMIS Fatigue Short Form 13a (SF-13a) Measure: Change from Baseline in PROMIS Sleep Disturbance Short Form 8a (SF-8a) Measure: Change from Baseline in SF-12 Health Survey (Physical Component Scores) Measure: Change from Baseline in SF-12 Health Survey (Mental Component Scores) Measure: Change from Baseline in DePaul Symptom Questionnaire (DSQ) Post-Exertional Malaise Measure: Composite Benefit Score
Completion date type changed
− Before
Estimated
+ After
Actual
Primary completion date changed
− Before
Aug 2026
+ After
6 Aug 2026
A Study of NE3107 in Early Parkinson's
NCT06757010 · BioVie Inc.
Main study measure wording changed
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Compare wording
− Before
Measure: Change from baseline in the MDS-UPDRS Part III
+ After
Measure: Monocyte Lymphocyte Ratio (MLR)
Participant count type changed
− Before
Estimated
+ After
Actual
Enrollment · participant count changed
− Before
60 participants (planned)
+ After
57 participants (actual)
Completion date type changed
− Before
Estimated
+ After
Actual
Recruitment status changed
− Before
Active not recruiting
+ After
Completed
NE3107 in Adults With Neurological Symptoms of Long COVID
NCT06847191 · BioVie Inc.
Main study measure wording changed
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Compare wording
− Before
Measure: Change from Baseline in performance on the Cogstate Cognition battery
+ After
Measure: Change from Baseline in performance on the Cogstate Cognition battery*
Participant count type changed
− Before
Estimated
+ After
Actual
Enrollment · participant count changed
− Before
208 participants (planned)
+ After
203 participants (actual)
Primary completion date changed
− Before
Jun 2026
+ After
Aug 2026
Recruitment status changed
− Before
Recruiting
+ After
Active not recruiting
A Study of NE3107 in Early Parkinson's
NCT06757010 · BioVie Inc.
Primary completion date changed
− Before
1 Dec 2025
+ After
1 May 2026
Recruitment status changed
− Before
Recruiting
+ After
Active not recruiting
NE3107 in Adults With Neurological Symptoms of Long COVID
NCT06847191 · BioVie Inc.
Main study measure wording changed
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Compare wording
− Before
Measure: Change in performance on the Cogstate Cognition battery
+ After
Measure: Change from Baseline in performance on the Cogstate Cognition battery
NE3107 in Adults With Neurological Symptoms of Long COVID
NCT06847191 · BioVie Inc.
Primary completion date changed
− Before
Nov 2025
+ After
Jun 2026